Yasushi Yoshida

Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities

Yasushi Yoshida, Nobuhiro Fujiki, Takeshi Nakajima et al. · European Journal of Neuroscience · 2001 · 444 citations

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

R Ohno, Kosuke Okada, T Masaoka et al. · Journal of Clinical Oncology · 1990 · 229 citations

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +15

Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation

Nobuhiro Fujiki, Yasushi Yoshida, Beth Ripley et al. · Neuroreport · 2001 · 217 citations

Homeostatic Mechanism, Food Deprivation, Food Restriction +22

Enantiodifferentiating <i>endo</i>‐Selective Oxylactonization of <i>ortho</i>‐Alk‐1‐enylbenzoate with a Lactate‐Derived Aryl‐λ³‐Iodane

Morifumi Fujita, Yasushi Yoshida, Kazuyuki Miyata et al. · Angewandte Chemie International Edition · 2010 · 200 citations

Natural Sciences, Diversity-oriented Synthesis, Asymmetric Synthesis +9

Effects of IV and ICV Hypocretin-1 (Orexin A) in Hypocretin Receptor-2 Gene Mutated Narcoleptic Dogs and IV Hypocretin-1 Replacement Therapy in a Hypocretin-ligand-deficient Narcoleptic Dog

Nobuhiro Fujiki, Yasushi Yoshida, Beth Ripley et al. · SLEEP · 2003 · 180 citations